Nagarajah, Subagini <br/><br/>
Reduced membrane attack complex formation in umbilical cord blood during Eculizumab treatment of the mother: a case report.  [electronic resource] 

 -  BMC nephrology  08 2019 
 - 307 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-2369 
<br/><br/><label>Standard No.: </label>10.1186/s12882-019-1469-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Humanized--metabolism<br/>Atypical Hemolytic Uremic Syndrome--drug therapy<br/>Complement C3--metabolism<br/>Complement C5a--metabolism<br/>Complement C9--metabolism<br/>Complement Inactivating Agents--metabolism<br/>Complement Membrane Attack Complex--drug effects<br/>Enzyme-Linked Immunosorbent Assay--methods<br/>Female<br/>Fetal Blood--immunology<br/>Humans<br/>Infant, Newborn<br/>Kidney Failure, Chronic--drug therapy<br/>Pregnancy<br/>Pregnancy Complications--drug therapy<br/>Recurrence